Hijack Bio

Hijack Bio is an early-stage biotech innovator pioneering targeted, biogenic drug delivery systems with an emphasis on environmental awareness. Operating from London, the company is developing a platform technology intended to enhance the efficacy and specificity of biotherapeutics, potentially addressing a critical bottleneck in modern medicine. As a private, pre-revenue entity likely in the pre-clinical stage, its success hinges on validating its platform and advancing programs toward clinical development. The company appears to be in a foundational phase, building its team and technology.

Environmentally aware targeted biogenic drug delivery systems for biotherapeutics.

The targeted drug delivery field is crowded with companies developing lipid nanoparticles, viral vectors, exosome platforms, and polymer-based systems. Hijack Bio must differentiate on superior targeting, payload versatility, or its stated environmental advantages to capture partnership interest.